Methods and compositions for treating and diagnosing diseases
Methods and compositions for diagnosing and treating diseases, particularly cancer, associated with differential expression of cancer-associated targets (CAT) in disease cells compared to healthy cells are provided. Also provided are antagonists and agonists of CAT, and methods for screening agents that modulate CAT level or activity in vivo or in vitro.
1. A method of diagnosing melanoma in an human, the method comprising detecting an elevated level of Na-K ATPase beta3 protein in a sample from the human relative to a control Na-K ATPase beta3 protein level that is representative of a non-cancerous sample, wherein the elevated level of Na-K ATPase beta3 protein indicates that said human has melanoma.
2. The method of claim 1 , wherein the amino acid sequence of the Na-K ATPase beta3 protein comprises a sequence selected from the group consisting of SEQ ID NOS:127-134.
3. The method of claim 1 , wherein the amino acid sequence of the Na-K ATPase beta3 protein consists of a sequence selected from the group consisting of SEQ ID NOS:127-134.
4. The method of claim 1 , wherein the elevated level of Na-K ATPase beta3 protein is detected by contacting the sample from the human with an isolated antibody that selectively binds to the Na-K ATPase beta3 protein and detecting binding of the antibody to the Na-K ATPase beta3 protein.
5. The method of claim 4 , wherein the antibody is coupled to a detectable substance.